Taylor McManus
YOU?
Author Swipe
View article: Systemic Treatment with the Janus Kinase Inhibitor Baricitinib in Ocular Chronic Graft-versus-Host Disease
Systemic Treatment with the Janus Kinase Inhibitor Baricitinib in Ocular Chronic Graft-versus-Host Disease Open
Proprietary or commercial disclosure may be found in the Footnotes and Disclosures at the end of this article.